<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
	<headerData>
        <submissionType>144/A</submissionType>
                <previousAccessionNumber>0001674324-26-000006</previousAccessionNumber>
                <filerInfo>
            <filer>
                <filerCredentials>
                    <cik>0001674324</cik>
                    <ccc>XXXXXXXX</ccc>
                </filerCredentials>
            </filer>
        <liveTestFlag>LIVE</liveTestFlag>




                </filerInfo>
    </headerData>

     <formData>
        <issuerInfo>
            <issuerCik>0001689375</issuerCik>
			<issuerName>ENTRADA THERAPEUTICS, INC.</issuerName>


			    <secFileNumber>001-40969</secFileNumber>


			<issuerAddress>
				<com:street1>ONE DESIGN CENTER PLACE</com:street1>
                				<com:street2>SUITE 17-500</com:street2>
                				<com:city>BOSTON</com:city>
				<com:stateOrCountry>MA</com:stateOrCountry>
				<com:zipCode>02210</com:zipCode>
			</issuerAddress>

			<issuerContactPhone>(857) 520-9158</issuerContactPhone>
			<nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>5AM Ventures V, L.P. </nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>

			<relationshipsToIssuer>
                                                                                                    <relationshipToIssuer>Affiliated stockholder</relationshipToIssuer>

			</relationshipsToIssuer>
		</issuerInfo>

				          <securitiesInformation>
			<securitiesClassTitle>Common Stock</securitiesClassTitle>
			<brokerOrMarketmakerDetails>
				<name>Goldman Sachs &amp; Co. LLC</name>
				<address>
				<com:street1>200 West Street</com:street1>
                				<com:city>New York</com:city>
				<com:stateOrCountry>NY</com:stateOrCountry>
				<com:zipCode>10282</com:zipCode>
				</address>
			</brokerOrMarketmakerDetails>
			<noOfUnitsSold>165578</noOfUnitsSold>
			<aggregateMarketValue>1084536</aggregateMarketValue>
			<noOfUnitsOutstanding>38820616</noOfUnitsOutstanding>
			<approxSaleDate>07/30/2026</approxSaleDate>
			<securitiesExchangeName>Nasdaq</securitiesExchangeName>
		</securitiesInformation>
                     <securitiesInformation>
			<securitiesClassTitle>Common Stock</securitiesClassTitle>
			<brokerOrMarketmakerDetails>
				<name>JonesTrading</name>
				<address>
				<com:street1>555 St. Charles Drive, Suite 200</com:street1>
                				<com:city>Thousand Oaks</com:city>
				<com:stateOrCountry>CA</com:stateOrCountry>
				<com:zipCode>91360</com:zipCode>
				</address>
			</brokerOrMarketmakerDetails>
			<noOfUnitsSold>165578</noOfUnitsSold>
			<aggregateMarketValue>1084536</aggregateMarketValue>
			<noOfUnitsOutstanding>38820616</noOfUnitsOutstanding>
			<approxSaleDate>07/30/2026</approxSaleDate>
			<securitiesExchangeName>Nasdaq</securitiesExchangeName>
		</securitiesInformation>

    		       <securitiesToBeSold>
         <securitiesClassTitle>Common Stock</securitiesClassTitle>
         <acquiredDate>10/12/2016</acquiredDate>
         <natureOfAcquisitionTransaction>Venture Financing Investment</natureOfAcquisitionTransaction>
                  <nameOfPersonfromWhomAcquired>Entrada Therapeutics, Inc.</nameOfPersonfromWhomAcquired>
                  <isGiftTransaction>N</isGiftTransaction>
		          <amountOfSecuritiesAcquired>331156</amountOfSecuritiesAcquired>
                  <paymentDate>10/12/2016</paymentDate>
                  <natureOfPayment>Cash</natureOfPayment>
      </securitiesToBeSold>

    <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>



        <noticeSignature>
            <noticeDate>08/10/2026</noticeDate>
                        <signature> /s/ Andrew J. Schwab</signature>
        </noticeSignature>
	</formData>
    </edgarSubmission>
